Quantitative Assessment of the T2 Relaxation Time of the Gluteus Muscles in Children with Duchenne Muscular Dystrophy: a Comparative Study Before and After Steroid Treatment |
Kim, Hee-Kyung
(Department of Radiology, Cincinnati Children's Hospital Medical Center)
Laor, Tal (Department of Radiology, Cincinnati Children's Hospital Medical Center) Horn, Paul S. (Department of Mathematical Sciences, University of Cincinnati) Wong, Brenda (Department of Neurology, Cincinnati Children's Hospital Medical Center) |
1 | Kight AC, Dardzinski BJ, Laor T, Graham TB. Magnetic resonance imaging evaluation of the effects of juvenile rheumatoid arthritis on distal femoral weight-bearing cartilage. Arthritis Rheum 2004;50:901-905 DOI ScienceOn |
2 | Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007;25:433-440 |
3 | DeSilva S, Drachman DB, Mellits D, Kuncl RW. Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Arch Neurol 1987;44:818-822 DOI ScienceOn |
4 | Sarnat HB. Neuromuscular disorder. In: Kliegman R, ed. Nelson textbook of pediatrics. Philadelphia: Saunders, 2007:1680-1696 |
5 | Chen YW, Nagaraju K, Bakay M, McIntyre O, Rawat R, Shi R, et al. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology 2005;65:826-834 DOI ScienceOn |
6 | Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103 DOI ScienceOn |
7 | Liu GC, Jong YJ, Chiang CH, Jaw TS. Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 1993;186:475-480 DOI |
8 | Kissel JT, Burrow KL, Rammohan KW, Mendell JR. Mononuclear cell analysis of muscle biopsies in prednisonetreated and untreated Duchenne muscular dystrophy. CIDD Study Group. Neurology 1991;41:667-672 DOI |
9 | Stern LM, Caudrey DJ, Perrett LV, Boldt DW. Progression of muscular dystrophy assessed by computed tomography. Dev Med Child Neurol 1984;26:569-573 |
10 | Dunn TC, Lu Y, Jin H, Ries MD, Majumdar S. T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology 2004;232:592-598 DOI ScienceOn |
11 | Muntoni F, Fisher I, Morgan JE, Abraham D. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord 2002;12:S162-S165 DOI ScienceOn |
12 | Davies KE. Challenges in Duchenne muscular dystrophy. Neuromuscul Disord 1997;7:482-486 DOI ScienceOn |
13 | Weller B, Massa R, Karpati G, Carpenter S. Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles. Muscle Nerve 1991;14:771-774 DOI ScienceOn |
14 | Patten C, Meyer RA, Fleckenstein JL. T2 mapping of muscle. Semin Musculoskelet Radiol 2003;7:297-305 DOI ScienceOn |
15 | Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging 1994;4:59-64 DOI ScienceOn |
16 | Bonifati DM, Witchel SF, Ermani M, Hoffman EP, Angelini C, Pegoraro E. The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy. J Neurol Neurosurg Psychiatry 2006;77:1177-1179 DOI ScienceOn |
17 | Sookhoo S, Mackinnon I, Bushby K, Chinnery PF, Birchall D. MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol 2007;62:160-165 DOI ScienceOn |
18 | Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, et al. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology 1991;41:661-666 DOI |
19 | Maillard SM, Jones R, Owens C, Pilkington C, Woo P, Wedderburn LR, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004;43:603-608 DOI |
20 | Strober JB. Therapeutics in duchenne muscular dystrophy. NeuroRx 2006;3:225-234 DOI ScienceOn |
21 | Swinyard CA, Deaver GG, Greenspan L. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil 1957;38:574-579 |
22 | Phoenix J, Betal D, Roberts N, Helliwell TR, Edwards RH. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 1996;19:302-310 DOI ScienceOn |